Atlas Trials

Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor

Clinical trial NCT03667092 · COMPLETED

Trial details

NCT number
NCT03667092
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Midgut Neuroendocrine Tumors
Start date
2018-09-01
Primary completion
2024-05-22
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.